Tam Jai International Honoured at The 15th Junzi Corporation Awards for Outstanding ESG and Business Practices

HONG KONG, Aug. 5, 2026 /PRNewswire/ -- Tam Jai International Co. Limited ("TJI", "Tam Jai" or the "Company", together with its subsidiaries, the "Group"), one of the leading restaurant groups in Hong Kong, is pleased to announce that it has been honoured with the "Junzi Corporation Award" at The Hang Seng University of Hong Kong ("HSUHK")'s 15th Junzi Corporation Awards Presentation Ceremony. This marks the Group's second receipt of the Award, following its recognition in 2024, and underscores the Group's steadfast commitment to upholding the highest standards of business ethics and social responsibility while driving sustainable corporate growth.

Mr Daren Lau, Chairman and Chief Executive Officer of TJI, said, "It is a tremendous honour for us to receive the Junzi Corporation Award for the second time. This recognition affirms our belief that long-term business success is underpinned by responsible and righteous decisions for our customers, employees and communities. Guided by our ESG core pillars of 'Nourishing Communities', 'Uplifting People' and 'Preserving Nature', we uphold high ethical standards as we advance our environmental and social initiatives alongside business growth. Looking ahead, we will continue to embed ESG principles across our operations and long-term strategy, with the aim of creating lasting sustainable value and strengthening the trust of our stakeholders."

Embodying the Junzi virtue of "Wisdom", the Group's financial performance has been significantly improved despite the challenging economic environment. TJI's flagship brands, TamJai Yunnan Mixian and TamJai SamGor Mixian ("SamGor"), continue to enjoy strong market penetration in Hong Kong, supported by the digital transformation of its CRM system to deepen customer engagement. Leveraging the solid foundation of these two brands, the Group has strengthened its presence in Hong Kong through a multi-brand strategy, successfully scaling Japanese dining brand Marugame Seimen and launching Yakiniku Yamagyu. Internationally, the Group has expanded its footprint to Australia, Malaysia and the Philippines through franchising and partnerships, adding to its existing network in Mainland China, Singapore and Japan.

Central to the core belief of the Junzi virtues, the Group's sustainable development strategy places strong emphasis on uplifting its people. Its signature "TJI Education Support Scheme for Employees' Children" has granted nearly HK$9 million in scholarships to more than 270 beneficiaries since 2015, while capability building is further advanced through various training initiatives, including the District Manager Leadership Programme and the Mastering Multi-Unit Training Programme for staff.

Further extending this spirit of care to the community, SamGor's food-giving initiative, "Mixian for the Good", has provided meals and warmth to over 60,000 people in need since 2021. On the environmental front, the Group makes strategic investments in green procurement, and its surplus pork belly upcycling campaign turns food waste into lifestyle products and workshops that foster green innovation, youth development and community care.

Since 2011, HSUHK has presented the "Junzi Corporation Awards" to recognise enterprises that uphold exemplary ethical standards while achieving profitable and sustainable operations. Participating corporations are evaluated by a judging panel, comprising experienced academics and industry practitioners, based on the Junzi "Five Virtues" of "Benevolence", "Righteousness", "Propriety", "Wisdom", and "Trustworthiness", which are the core values of Confucianism.

– End –

About Tam Jai International Co. Limited

As one of the leading restaurant groups in Hong Kong, TJI has rapidly expanded its network to over 250 stores across various markets, including Mainland China, Singapore, Japan, Australia, Malaysia and the Philippines. Apart from self-operating restaurants, the Group also adopts alternative models such as joint venture, franchise or strategic partnership for overseas markets. The Group's portfolio of distinguished brands includes TamJai Yunnan Mixian (譚仔雲南米線), TamJai SamGor Mixian (譚仔三哥米線), and international brand TamJai Mixian, as well as Japanese dining brands, Marugame Seimen and Yakiniku Yamagyu, through franchise and licensing in Hong Kong.

With highly standardised operations, an innovative spirit and an efficient management model, TJI is committed to providing customers with a quality yet affordable dining experience while ambitiously expanding its footprint across the globe.

For Press Enquiries
Strategic Financial Relations Limited
Iris Lee	Tel: (852) 2864 4829
Veron Ng	Tel: (852) 2864 4831
Carol Cheung	Tel: (852) 2114 2200
Email:	sprg_tji@sprg.com.hk

For Press Enquiries

Strategic Financial Relations Limited

Iris Lee

Tel: (852) 2864 4829

Veron Ng

Tel: (852) 2864 4831

Carol Cheung

Tel: (852) 2114 2200

Email:

sprg_tji@sprg.com.hk 

 

** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **

Tam Jai International Honoured at The 15th Junzi Corporation Awards for Outstanding ESG and Business Practices

Advanced Capsule Technology for Improved Digestive Enzyme Delivery

SEOUL, South Korea, Aug. 5, 2026 /PRNewswire/ -- Lonza Capsugel has released new peer-reviewed research showing that its Licaps^® DUOCAP^® capsule-in-capsule technology can significantly improve the protection and targeted delivery of acid-sensitive enzymes in the gastrointestinal (GI) tract. Conducted in collaboration with ProDigest (Belgium), leading experts in preclinical gastrointestinal tract models, the study highlights the impact of dual-release capsule technologies in unlocking advanced product development opportunities and reinforces the importance of delivery choice for nutraceutical products

Published in Pharmaceutics, the study used the Simulator of the Human Intestinal Microbial Ecosystem (SHIME)^® in vitro model to compare multiple capsule polymers and formulations under realistic fed and fasted digestive conditions. To assess dissolution behavior, capsules contained caffeine as a marker of capsule dissolution, as well as pancreatin, an acid-sensitive digestive enzyme that is converted from tributyrin to butyrate when it reaches the upper small intestine. Five capsule formulations, including two single capsule types and three Licaps^® DUOCAP^® capsule-in-capsule configurations, were assessed for dissolution timing, ingredient protection and enzyme activity throughout the upper gastrointestinal tract, with particular focus on the upper small intestine where digestive enzymes are most effective.

When taken with food, the Licaps^® DUOCAP^® capsule-in-capsule formulations demonstrated superior protection and targeted release profiles, with caffeine released at the end of the duodenum and/or jejunum and a high butyrate recovery, ranging from 53% to 87%. Enzyme activity was up to four times higher in the upper small intestine compared to standard immediate-release capsules. In contrast, the immediate-release single capsule format released a high level of its contents in the stomach, as shown by low butyrate recovery in the upper small intestine (16–21%). This suggests gastric degradation of the unprotected enzyme, meaning that the intended delivery was significantly impaired when compared to the Licaps^® DUOCAP^® capsule-in-capsule technology.

Dr. Elnaz Karimian Azari, Senior Manager R&D, Lonza Capsugel and lead author of the study, said:

"This study further reinforces the robustness and reliability of our Licaps^® DUOCAP^® capsule-in-capsule technology, providing independent, peer-reviewed validation of its ability to deliver sensitive ingredients to targeted regions of the gastrointestinal tract. While this work focused on release in the upper small intestine, it builds on a growing body of evidence demonstrating that Licaps^® DUOCAP^® capsules can protect and transport ingredients like live probiotics all the way to the colon, where they are needed to achieve optimal performance. It also highlights just how important capsule selection is to the success and effectiveness of nutraceutical products – and why delivery really does matter."

Experience the Future of Oral Delivery at CPHI Korea 2026

As one of Asia's premier pharmaceutical and nutraceutical industry events, CPHI Korea 2026 brings together innovators, formulators, manufacturers, and industry leaders to explore the latest advancements shaping the future of healthcare and nutrition. The event serves as a key platform for networking, knowledge exchange, and discovering breakthrough technologies that enable next-generation product development

Join our experts at Booth K15, COEX, Seoul, South Korea, from 25-27 August 2026, to explore the latest scientific advancements in targeted ingredient delivery, discuss your formulation challenges, and learn how innovative capsule technologies can accelerate your next product innovation. Whether you are developing digestive health solutions, probiotics, oral biologics, or next-generation nutraceutical products, our team will be available to share insights and collaborate on tailored delivery strategies.

** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **

Leading the Future of Oral Delivery, Lonza Capsugel brings breakthrough Capsule Technologies to the Korean Market at CPHI Korea